Delivery Order SPE2DB22D1017-SPE2DB24FF3ZY
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $1,097.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with a completion date of March 5, 2024. This award is part of a larger single-award indefinite delivery contract (IDC) worth up to $999,999,999.00...
- The U.S. Department of Defense's Medical Supply Chain (also known as DLA Troop Support Medical) has awarded a Delivery Order contract valued at $6,150.84 to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a prescription medication. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency, valued up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The contract is valued at $7,085.94 and has a period of performance through March 22, 2024. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract has a potential value of $3,291.24 and a completion date of January 29, 2024. AmerisourceBergen Drug Corp serves as the prime contractor, providing these specialty medications to support military treatment programs and facilities. This delivery...
- The Defense Logistics Agency (DLA) awarded a $1,373.46 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. This delivery order has a completion date of March 1, 2024 and was awarded on February 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a $263,299.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order valued at $29,124.24 to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML prescription medication. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows DLA to efficiently procure...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,194.16 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. This award is part of an indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued up to $999,999,999.00, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $4,388.32 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products. This award is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary contract vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $3,720.92 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will deliver the products from its corporate office in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF3ZYDelivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,467.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products, with a performance period through March 12, 2024. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical and medical supply products to support military treatment programs and facilities under various DLA contracts, which do not typically have set-aside designations. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp as the sole prime contractor, enabling the company to deliver a comprehensive range of medications and healthcare materials to DLA Troop Support Medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 3/11/24 |